Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126357681 | 12635768 | 1 | I | 20131224 | 20160809 | 20160809 | EXP | JP-ROCHE-1326387 | ROCHE | MORITA R, SAKURADA TOMOYA, KOBAYASHI ERIKO, ET AL. SUN-P3-507 EVALUATION OF INFORMATION ON ANTI-INFLUENZA DRUGS FOR PREGNANT WOMEN AND USE OF ANTI-INFLUENZA DRUGS DURING PREGNANCY. ABSTRACTS OF THE 23RD ANNUAL MEETING OF JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES(FROM 21 SEP 2013 TO 22 SEP 2013)/ SENDAI-CITY, MIYAGI ()435/() ;:-. | 41.00 | YR | F | Y | 0.00000 | 20160809 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126357681 | 12635768 | 1 | PS | TAMIFLU | OSELTAMIVIR PHOSPHATE | 1 | Oral | 21087 | 75 | MG | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126357681 | 12635768 | 1 | Influenza |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126357681 | 12635768 | Maternal exposure during pregnancy | |
| 126357681 | 12635768 | Premature labour |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126357681 | 12635768 | 1 | 20090119 | 20090123 | 0 |